Follow
Elisa Garbayo
Elisa Garbayo
Department of Pharmaceutical Sciences, University of Navarra
Verified email at unav.es
Title
Cited by
Cited by
Year
Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia–reperfusion model
FR Formiga, B Pelacho, E Garbayo, G Abizanda, JJ Gavira, ...
Journal of Controlled Release 147 (1), 30-37, 2010
2522010
Effective GDNF brain delivery using microspheres—a promising strategy for Parkinson's disease
E Garbayo, CN Montero-Menei, E Ansorena, JL Lanciego, MS Aymerich, ...
Journal of Controlled Release 135 (2), 119-126, 2009
1742009
Advances in Parkinson’s disease: 200 years later
NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ...
Frontiers in neuroanatomy 12, 113, 2018
1572018
Heart regeneration after myocardial infarction using synthetic biomaterials
S Pascual-Gil, E Garbayo, P Díaz-Herráez, F Prosper, MJ Blanco-Prieto
Journal of Controlled Release 203, 23-38, 2015
1512015
The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats
GJR Delcroix, E Garbayo, L Sindji, O Thomas, C Vanpouille-Box, ...
Biomaterials 32 (6), 1560-1573, 2011
1482011
Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through …
FR Formiga, B Pelacho, E Garbayo, I Imbuluzqueta, P Díaz-Herráez, ...
Journal of Controlled Release 173, 132-139, 2014
1412014
Hydrogel based approaches for cardiac tissue engineering
L Saludas, S Pascual-Gil, F Prósper, E Garbayo, M Blanco-Prieto
International journal of pharmaceutics 523 (2), 454-475, 2017
1342017
EF1α and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells
KM Curtis, LA Gomez, C Rios, E Garbayo, AP Raval, MA Perez-Pinzon, ...
BMC molecular biology 11, 1-15, 2010
1202010
Organotypic cultures as tools for optimizing central nervous system cell therapies
N Daviaud, E Garbayo, PC Schiller, M Perez-Pinzon, CN Montero-Menei
Experimental neurology 248, 429-440, 2013
992013
Nanomedicine and drug delivery systems in cancer and regenerative medicine
E Garbayo, S Pascual‐Gil, C Rodríguez‐Nogales, L Saludas, ...
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 12 (5 …, 2020
962020
Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems
E Garbayo, E Ansorena, MJ Blanco-Prieto
Maturitas 76 (3), 272-278, 2013
962013
Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion
E Garbayo, JJ Gavira, MG de Yebenes, B Pelacho, G Abizanda, H Lana, ...
Scientific Reports 6 (1), 25932, 2016
692016
Micro-and nanotechnology approaches to improve Parkinson's disease therapy
PV Torres-Ortega, L Saludas, AS Hanafy, E Garbayo, MJ Blanco-Prieto
Journal of controlled release 295, 201-213, 2019
682019
Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres
E Garbayo, E Ansorena, JL Lanciego, MS Aymerich, MJ Blanco-Prieto
European journal of pharmaceutics and biopharmaceutics 69 (3), 844-851, 2008
642008
Neuroprotective properties of marrow‐isolated adult multilineage‐inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic …
E Garbayo, AP Raval, KM Curtis, D Della‐Morte, LA Gomez, G D’Ippolito, ...
Journal of neurochemistry 119 (5), 972-988, 2011
602011
Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys
E Garbayo, E Ansorena, H Lana, M del Mar Carmona-Abellan, I Marcilla, ...
Biomaterials 110, 11-23, 2016
592016
Brain aging and Parkinson’s disease: New therapeutic approaches using drug delivery systems
C Rodríguez-Nogales, E Garbayo, MM Carmona-Abellán, MR Luquin, ...
Maturitas 84, 25-31, 2016
572016
Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
E Garbayo, E Ansorena, JL Lanciego, MJ Blanco‐Prieto, MS Aymerich
Movement disorders 26 (10), 1943-1947, 2011
532011
Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model
S Pascual-Gil, T Simón-Yarza, E Garbayo, F Prósper, MJ Blanco-Prieto
International journal of pharmaceutics 523 (2), 531-533, 2017
502017
Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson’s disease
N Daviaud, E Garbayo, N Lautram, F Franconi, L Lemaire, ...
Neuroscience 256, 10-22, 2014
492014
The system can't perform the operation now. Try again later.
Articles 1–20